FuturHealth

FuturHealth

Telehealth weight management with personalized prescriptions

Overview

FuturHealth uses telehealth to provide personalized weight management with prescription medications (including GLP-1 therapies), coaching, and diet plans delivered to homes across the United States. It starts with an online assessment, followed by doctor consultations to tailor a prescription, and ongoing support through a subscription that includes meal plans and medications. The platform connects patients with doctors for prescriptions and offers continuous care with regular follow-ups. It stands out by focusing on individual needs rather than generic programs and makes comprehensive weight-management care accessible nationwide through a subscription model.

Significant Headcount Growth

About FuturHealth

Simplify's Rating
Why FuturHealth is rated
C
Rated C on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Consumer Software

Healthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

San Diego, California

Founded

2024

Get referred to FuturHealth

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • January 2026 oral Wegovy access reduces injection resistance and expands eligible demand.
  • April 2026 Foundayo coverage adds another next-generation GLP-1 option for members.
  • Affirm financing lowers upfront cost barriers, supporting conversion in a $198 monthly program.

What critics are saying

  • Goglia Nutrition won a January 30, 2026 injunction forcing FuturHealth off metabolic typing.
  • That lawsuit demands escrow of shared-customer revenues, squeezing cash through 2026.
  • Only $5 million raised leaves FuturHealth vulnerable if GLP-1 margins compress or litigation escalates.

What makes FuturHealth unique

  • FuturHealth bundles telehealth, GLP-1s, dietitians, Apple Fitness+, and financing in one subscription.
  • January 26, 2026 Wegovy pill launch broadened its non-injectable obesity offering nationwide.
  • The company claims 1.5 million clients, signaling unusually large consumer reach for a seed-funded startup.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Remote Work Options

Unlimited Paid Time Off

Growth & Insights and Company News

Headcount

6 month growth

13%

1 year growth

13%

2 year growth

13%
PR Newswire
Apr 28th, 2026
FuturHealth launches Eli Lilly's oral GLP-1 pill Foundayo, removing injection barrier for 400K members

FuturHealth, a clinically-guided health platform, has announced it will offer orforglipron, Eli Lilly's oral GLP-1 receptor agonist marketed as Foundayo, through its nationwide service. The once-daily pill will be prescribed by affiliated clinical providers to eligible members and delivered via licensed pharmacy. Clinical trials showed patients with obesity lost an average of 12% of their body weight (approximately 27 pounds) over 72 weeks at the highest dose, alongside improvements in blood sugar control. The oral medication requires no food or water timing restrictions. FuturHealth's programme starts at $198 per month and combines medication access with personalised guidance on nutrition, movement and lifestyle. The company has served 400,000 people. The addition reflects growing demand for non-injectable GLP-1 alternatives, addressing needle-related barriers to treatment.

PR Newswire
Jan 26th, 2026
FuturHealth adds FDA-approved Wegovy pill to $198/month weight-loss programme with 17% results

FuturHealth, a personalized health and weight-loss platform, has expanded its care options to include the Wegovy pill, the first FDA-approved oral GLP-1 medication. The company's $198 monthly programme combines the prescription with medical support, Apple Fitness+ access, and optional customised meal plans. Founded in San Diego, FuturHealth has supported hundreds of thousands of members through its integrated approach. The addition of oral medication provides more flexibility for patients, with clinical providers evaluating each case individually for eligibility. Members can transition from injectable to oral therapy based on their clinical profile. According to FuturHealth's obesity specialist, the Wegovy pill has demonstrated average weight loss of approximately 17% when combined with lifestyle changes. The company positions itself as offering the most affordable FDA-approved GLP-1 option available.

The Mac Observer
Aug 11th, 2025
Apple Fitness+ Now Available Free to All FuturHealth Subscribers

Apple Fitness+ is expanding through a new partnership with FuturHealth, a subscription-based weight-loss service.

HIT Consultant
Mar 25th, 2025
Affirm + Futurhealth Partner To Make Glp-1 Medications More Accessible With Flexible Payment Options

What You Should Know: – FuturHealth, a provider of personalized weight-loss solutions partners with Affirm, the payment network that empowers consumers and helps merchants drive growth. – The collaboration will enable FuturHealth customers to use Affirm’s flexible, transparent pay-over-time options to purchase medications and wellness solutions.Flexible, Transparent Way to Pay Over Time for GLP-1 Medications and Wellness SolutionsNow, FuturHealth customers who are approved can finance the purchase of various weight-loss medications, including branded GLP-1 options such as Wegovy and Ozempic, as well as personalized meal plans, consultations, and lab services.These medications and wellness solutions have proven effective in managing weight and related health conditions but often come with a significant cost, sometimes exceeding $1000 per month. By integrating Affirm, FuturHealth aims to provide a more accessible and responsible way for customers to afford these important treatments and services.How it WorksApplying for Affirm is straightforward. During checkout on FuturHealth’s website, customers can select Affirm as their preferred payment method. They will then undergo a quick eligibility check. If approved, customers can choose from customized biweekly or monthly payment plans, with interest rates as low as 0% APR, and confirm their purchase.Affirm adheres to responsible lending practices, ensuring that customers are only approved for financing that Affirm believes they can repay. Furthermore, Affirm does not charge any late or hidden fees, providing customers with a transparent and predictable payment experience.AvailabilityCustomers can now visit FuturHealth’s website and select Affirm as a payment option when purchasing their weight-loss medications and services

PR Newswire
Jan 29th, 2025
Futurhealth Appoints Dr. Brian Solow, Md, Faafp To Advisory Team

Dr. Solow's Expertise is posted to Guide FuturHealth's Expansion in Personalized Weight Loss SolutionsSAN DIEGO, Jan. 28, 2025 /PRNewswire/ -- FuturHealth , a leading provider of personalized weight-loss solutions, today announced the appointment of Dr. Brian Solow to its medical advisory team. Dr. Solow brings more than 30 years of experience in healthcare, including obesity care, clinical research, and the integration of GLP-1 medications into sustainable weight-loss treatments.Dr

Recently Posted Jobs

Sign up to get curated job recommendations

FuturHealth is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →